2505 related articles for article (PubMed ID: 16950146)
21. Hybrid imaging (SPECT/CT and PET/CT)--improving the diagnostic accuracy of functional/metabolic and anatomic imaging.
Even-Sapir E; Keidar Z; Bar-Shalom R
Semin Nucl Med; 2009 Jul; 39(4):264-75. PubMed ID: 19497403
[TBL] [Abstract][Full Text] [Related]
22. Incremental value of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma.
Chen L; Luo Q; Shen Y; Yu Y; Yuan Z; Lu H; Zhu R
J Nucl Med; 2008 Dec; 49(12):1952-7. PubMed ID: 18997044
[TBL] [Abstract][Full Text] [Related]
23. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
Zanzonico P; Dauer L; St Germain J
Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
[TBL] [Abstract][Full Text] [Related]
24. PET versus SPECT: strengths, limitations and challenges.
Rahmim A; Zaidi H
Nucl Med Commun; 2008 Mar; 29(3):193-207. PubMed ID: 18349789
[TBL] [Abstract][Full Text] [Related]
25. Attenuation correction of somatostatin receptor SPECT by integrated low-dose CT: is there an impact on sensitivity?
Steffen IG; Mehl S; Heuck F; Elgeti F; Furth C; Amthauer H; Ruf J
Clin Nucl Med; 2009 Dec; 34(12):869-73. PubMed ID: 20139819
[TBL] [Abstract][Full Text] [Related]
26. Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance.
Coleman RE; Delbeke D; Guiberteau MJ; Conti PS; Royal HD; Weinreb JC; Siegel BA; Federle MF; Townsend DW; Berland LL; ; ;
J Nucl Med; 2005 Jul; 46(7):1225-39. PubMed ID: 16000293
[TBL] [Abstract][Full Text] [Related]
27. [SPECT/CT fusion imaging for the diagnosis of benign and malignant lesions in bones].
Zhao Z; Li FL; Zhao LX; Su MG
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Nov; 39(6):1036-9. PubMed ID: 19253855
[TBL] [Abstract][Full Text] [Related]
28. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
29. PET/CT: panacea, redundancy, or something in between?
Vogel WV; Oyen WJ; Barentsz JO; Kaanders JH; Corstens FH
J Nucl Med; 2004 Jan; 45 Suppl 1():15S-24S. PubMed ID: 14736832
[TBL] [Abstract][Full Text] [Related]
30. [Bony pathologies of the metacarpophalangeal joints in early rheumatoid arthritis: comparison of MRI and high-resolution SPECT].
Scherer A; Wirrwar A; Mattes-György K; Blondin D; Reichelt D; Müller HW; Schneider M; Mödder U; Ostendorf B
Rofo; 2009 Sep; 181(9):875-80. PubMed ID: 19517338
[TBL] [Abstract][Full Text] [Related]
31. Interobserver reliability in the interpretation of diagnostic lumbar MRI and nuclear imaging.
Mulconrey DS; Knight RQ; Bramble JD; Paknikar S; Harty PA
Spine J; 2006; 6(2):177-84. PubMed ID: 16517390
[TBL] [Abstract][Full Text] [Related]
32. Multimodality imaging of structure and function.
Townsend DW
Phys Med Biol; 2008 Feb; 53(4):R1-R39. PubMed ID: 18263942
[TBL] [Abstract][Full Text] [Related]
33. Directions and magnitudes of misregistration of CT attenuation-corrected myocardial perfusion studies: incidence, impact on image quality, and guidance for reregistration.
Kennedy JA; Israel O; Frenkel A
J Nucl Med; 2009 Sep; 50(9):1471-8. PubMed ID: 19690038
[TBL] [Abstract][Full Text] [Related]
34. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data.
Martinez-Möller A; Souvatzoglou M; Delso G; Bundschuh RA; Chefd'hotel C; Ziegler SI; Navab N; Schwaiger M; Nekolla SG
J Nucl Med; 2009 Apr; 50(4):520-6. PubMed ID: 19289430
[TBL] [Abstract][Full Text] [Related]
35. Incremental value of 111-in pentetreotide SPECT/CT fusion imaging of neuroendocrine tumors.
Wong KK; Cahill JM; Frey KA; Avram AM
Acad Radiol; 2010 Mar; 17(3):291-7. PubMed ID: 19962915
[TBL] [Abstract][Full Text] [Related]
36. Multimodality molecular imaging with combined optical and SPECT/PET modalities.
Culver J; Akers W; Achilefu S
J Nucl Med; 2008 Feb; 49(2):169-72. PubMed ID: 18199608
[TBL] [Abstract][Full Text] [Related]
37. PET & SPECT instrumentation.
Spanoudaki VC; Ziegler SI
Handb Exp Pharmacol; 2008; (185 Pt 1):53-74. PubMed ID: 18626798
[TBL] [Abstract][Full Text] [Related]
38. Roles of nuclear cardiology, cardiac computed tomography, and cardiac magnetic resonance: assessment of patients with suspected coronary artery disease.
Berman DS; Hachamovitch R; Shaw LJ; Friedman JD; Hayes SW; Thomson LE; Fieno DS; Germano G; Slomka P; Wong ND; Kang X; Rozanski A
J Nucl Med; 2006 Jan; 47(1):74-82. PubMed ID: 16391190
[TBL] [Abstract][Full Text] [Related]
39. Multimodal imaging approaches: PET/CT and PET/MRI.
Pichler BJ; Judenhofer MS; Pfannenberg C
Handb Exp Pharmacol; 2008; (185 Pt 1):109-32. PubMed ID: 18626801
[TBL] [Abstract][Full Text] [Related]
40. The role of single-photon emission computed tomography/computed tomography for precise localization of metastases in patients with differentiated thyroid cancer.
Wang H; Fu HL; Li JN; Zou RJ; Gu ZH; Wu JC
Clin Imaging; 2009; 33(1):49-54. PubMed ID: 19135930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
